Dunwiddie T V, Worth T S, Olsson R A
Naunyn Schmiedebergs Arch Pharmacol. 1986 Sep;334(1):77-85. doi: 10.1007/BF00498743.
Previous studies have shown that analogs of adenosine with substituents upon the N6-nitrogen (e.g., N6-[1-phenyl-2(R)-propyl]adenosine; R-PIA) are often much more potent than the parent compound in activating adenosine receptors, particularly those of the A1 subtype. The present investigation characterized the potencies of a number of N6-substituted adenosine analogs in depressing excitatory synaptic transmission in slices of rat hippocampus, an electrophysiological response mediated by receptors of the A1 subtype. These potencies correlated well with previously reported affinities of these analogs for A1 receptor sites in brain, but not with coronary vasodilation in the dog heart, an A2 receptor mediated response. Analogs with alkyl or aryl substituents at the N6 position were generally more potent than adenosine, although analogs with a tertiary carbon attached directly to the N6-nitrogen were usually only weakly active. Although it has been suggested that there may be a subregion of the A1 receptor with some specificity for aryl groups, these experiments did not suggest that this was the case. Analogs with chiral centers attached to the N6-nitrogen usually displayed stereoselectivity, with R-isomers more potent than the S-isomers. The mechanism underlying this selectivity appeared to be both a facilitating effect of alkyl substituents in the propyl C1 position of R-PIA, and a hindering effect of substituents in the position normally occupied by the hydrogen attached to propyl C2 of R-PIA. These results indicate that although there are some similarities in terms of requirements for activity at A1 and A2 receptors, differences between the N6 sub-regions of these receptors are sufficient to permit the development of selective analogs for these two receptor sites.
先前的研究表明,在N6-氮原子上带有取代基的腺苷类似物(例如,N6-[1-苯基-2(R)-丙基]腺苷;R-PIA)在激活腺苷受体,尤其是A1亚型受体时,往往比母体化合物更具活性。本研究对多种N6-取代腺苷类似物在抑制大鼠海马切片兴奋性突触传递方面的活性进行了表征,这种电生理反应是由A1亚型受体介导的。这些活性与先前报道的这些类似物对脑内A1受体位点的亲和力密切相关,但与犬心脏中的冠状动脉舒张无关,后者是由A2受体介导的反应。在N6位置带有烷基或芳基取代基的类似物通常比腺苷更具活性,尽管直接连接到N6-氮原子上带有叔碳的类似物通常活性较弱。尽管有人提出A1受体可能存在一个对芳基具有一定特异性的亚区域,但这些实验并未表明情况如此。连接到N6-氮原子上带有手性中心的类似物通常表现出立体选择性,R-异构体比S-异构体更具活性。这种选择性背后的机制似乎既是R-PIA丙基C1位置上烷基取代基的促进作用,也是R-PIA丙基C2位置上通常被氢占据的位置上取代基的阻碍作用。这些结果表明,尽管A1和A2受体在活性要求方面存在一些相似之处,但这些受体的N6亚区域之间的差异足以允许开发针对这两个受体位点的选择性类似物。